
Nexcital10 mg
Unimed Unihealth MFG. Ltd.
Established (Approved) Uses Escitalopram is approved for the treatment of Major Depressive Disorder (MDD) in adults and in adolescents 12 years of age and older.
Escitalopram is approved for the treatment of Major Depressive Disorder (MDD) in adults and in adolescents 12 years of age and older. Escitalopram is also approved for the treatment of Generalized Anxiety Disorder (GAD) in adults and in children and adolescents 7 years of age and older.
Escitalopram is used, and is approved in many countries including Bangladesh and across Europe, for panic disorder (with or without agoraphobia) and for social anxiety disorder (social phobia) in adults, based on clinical trial evidence, although these uses are not FDA-approved indications in the United States.
Escitalopram is sometimes prescribed off-label for obsessive-compulsive disorder (OCD) in adults, based on the general antidepressant/anti-obsessional effect of SSRIs as a class, although Escitalopram does not carry a specific regulatory approval for OCD in most markets and other SSRIs have stronger evidence in this indication. Any off-label use of Escitalopram should be decided by a qualified physician after weighing individual benefits and risks.
The dose and duration of treatment with Escitalopram must be determined by a qualified healthcare professional based on the specific condition being treated, the patient's age, and individual response. Escitalopram is not dosed the same way for every indication, and doses should never be adjusted or stopped without medical advice.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.